Technology News and Research

RSS

e-infrastructure to tackle diseases

Disease knows no borders and now researchers in Europe and the Mediterranean shoreline are using electronic infrastructures (e-Infrastructures) to coordinate and cooperate internationally.

19 Aug 2009

CryoLife's SynerGraft technology effective in removing donor cells and cellular remnants from the tissue

CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, today announced the first three implantations of the CryoPatch((R)) SG pulmonary human cardiac patch since FDA clearance.

19 Aug 2009

Minnetronix announces Charles Garcia as President of Twin Cities Professional Chapter of the Society of Hispanic Professional Engineers

Minnetronix, a medical device design and manufacturing firm, is proud to announce the appointment of Charles Garcia, Business Development Manager, as President of the Twin Cities Professional Chapter of the Society of Hispanic Professional Engineers (SHPE).

19 Aug 2009

Aaron Whiteman to be the new CEO of GENova Biotherapeutics

GENova Biotherapeutics, Inc., ("GENova") - (OTCBB: GVBP.OB), a biotechnology company that identifies, acquires, and develops novel drug targets that disrupt the advance of life-threatening diseases, today named Aaron Whiteman as its Chief Executive Officer.

19 Aug 2009

Fruit flies' fat-store levels can be measured and controlled by brain neuron manipulation

A team of scientists from the California Institute of Technology (Caltech) have pinpointed two groups of neurons in fruit fly brains that have the ability to sense and manipulate the fly's fat stores in much the same way as do neurons in the mammalian brain.

19 Aug 2009

Obama calls for veterans' health care expansion

President Obama Monday included health care in a speech at the Veterans of Foreign Wars' national convention Monday, The Arizona Republic reports.

19 Aug 2009

Agito Networks announces 2009 CIO 100 award winner

Agito Networks, Inc.(TM), the company delivering innovative solutions in enterprise mobility, today announced that customer Anthony Marano Company is a recipient of the 2009 CIO 100 Award. Anthony Marano Company was distinguished for its enterprise fixed mobile convergence (eFMC) project, which is powered by Agito Networks' RoamAnywhere(TM) Mobility Router(TM).

19 Aug 2009

Abbott collaborates with Velcera to market pain management product for pets

Abbott (NYSE: ABT) announced today they have partnered with Velcera, Inc., a specialty pharmaceutical company focused on pet health, to market the first canine pain management product delivered in a transmucosal mist form. Currently in clinical trials, the product combines the proven pain medication meloxicam, a nonsteroidal anti-inflammatory drug (NSAID) with Velcera's patented Promist(TM) technology, and has been globally licensed for pain management in dogs

19 Aug 2009

Aethlon Medical Chairman to present at the 14th Annual Southern California Investor Conference

Aethlon Medical, Inc. (OTC Bulletin Board: AEMD) announced that it will present at today's 14th Annual Southern California Investor Conference being held at the Island Hotel in Newport Beach, California.

19 Aug 2009

Affiliated Computer Services collaborates with clients to develop business solutions for managing downturn

As companies and government agencies navigate unprecedented economic challenges, some organizations are finding innovative ways to save money but also improve services and productivity. Affiliated Computer Services, Inc. (NYSE: ACS) is working closely with its clients to develop successful business solutions designed to help them manage the economic downturn and prepare for the eventual rebound.

19 Aug 2009

George Rehm and David Mahoney joins Adamas' Board of Directors

Adamas Pharmaceuticals, Inc., a privately held company, announced today that it has closed a $40 million Series D round of funding led by aeris CAPITAL AG and DAG Ventures. Earlier investors MDV-Mohr Davidow Ventures and Northgate Capital also participated in the round. In conjunction with the financing, the company announced the election of George M. Rehm, Managing Partner of aeris CAPITAL AG, and David L. Mahoney, a private equity investor, to the company's Board of Directors.

19 Aug 2009

American Asthma Foundation awards $750,000 to Dr.Charles Zuker

Dr. Charles Zuker, a renowned expert on the nerves that determine taste and smell, has been awarded $750,000 by the American Asthma Foundation (AAF). Dr. Zuker will apply his expertise to asthma by defining the nerves that contract the airways during an asthma attack in order to reduce the severity of these episodes.

19 Aug 2009

Labcyte awarded 2nd Japanese patent for acoustic-based cell sorting system

Labcyte, the company that developed and commercialized the acoustic transfer of liquids today announced that the Japanese patent office has granted patent 4309131 that covers the design of an acoustic-based system that can sort cells based upon acoustic or other properties and then eject them specifically from a mixed population.

18 Aug 2009

Novel genome-analysis strategy to speed search for gene-disease links

University of Washington (UW) researchers have successfully developed a novel genome-analysis strategy for more rapid, lower cost discovery of possible gene-disease links. By saving time and lowering expenses, the approach makes it feasible for scientists to search for disease-causing genes in people with the same inherited disorder but without any family ties to each other.

18 Aug 2009

Synco Bio to manufacture Versartis type 2 diabetes drug candidate

SynCo Bio Partners, a Netherlands based biopharmaceutical contract manufacturer, and Versartis, Inc. today announced a strategic partnership to produce Versartis' lead drug candidate VRS-859, a novel GLP-1 analog for monthly dosing to treat type 2 diabetes Under the agreement, SynCo will further develop the Versartis existing production process for VRS-859 and optimize the manufacturing process to increase yields for the forthcoming cGMP production.

18 Aug 2009

Ormco Corporation and Align Technology agree to collaborate and settle patent litigation

Ormco Corporation, a subsidiary of Danaher Corporation (NYSE: DHR) today announced that Ormco and Align Technology, Inc. (Nasdaq: ALGN) have agreed to enter into an exclusive collaboration arrangement to jointly develop and market an orthodontic product offering that will provide orthodontic patients a treatment solution that involves a combination of Align's Invisalign(R) system and Ormco's Insignia(R) custom orthodontic bracket and arch wire system.

From Danaher 18 Aug 2009

DNA evidence found at crime scenes can easily be falsified

Nucleix, Ltd., an emerging life science company specializing in forensic DNA analysis, announced that company researchers have proven DNA evidence found at crime scenes can easily be falsified using basic equipment, know-how and access to DNA or a DNA database.

18 Aug 2009

New technology for measuring heart rate via a conventional wrist watch

SPO Medical Inc. (SPOM) announced today that it has successfully demonstrated to several leading sports and fitness watch manufacturers its vital sign technology for measurement of the heart rate via a conventional wrist watch, negating the need of the traditional chest strap currently used by most sports watch manufacturers.

18 Aug 2009

Tiny magnetic particles guide stem cells to damaged tissue

Microscopic magnetic particles have been used to bring stem cells to sites of cardiovascular injury in a new method designed to increase the capacity of cells to repair damaged tissue, UCL scientists announced today.

18 Aug 2009

Human Genome Sciences achieves systemic lupus goals with candidate drug

Human Genome Sciences announced that BENLYSTA™ met the primary endpoint in BLISS-52, the first of two pivotal Phase 3 trials in patients with serologically active systemic lupus erythematosus (SLE). These results show that BENLYSTA™ has the potential to become the first new approved drug in decades giving hope to people living with systemic lupus.

17 Aug 2009